201
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Sonic vibration ameliorates inflammatory diseases via the up-regulation of IL-10

, , , , &
Pages 161-170 | Received 29 Jan 2024, Accepted 18 Apr 2024, Published online: 26 Apr 2024

References

  • Abdellaoui N, Kim SY, Kim MS. 2023. Effect of TRAF6-knockout on gene expression and lncRNA expression in Epithelioma papulosum cyprini (EPC) cells. Animal Cells Syst. 27:197–207. doi:10.1080/19768354.2023.2263070.
  • Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol. Jul; 4:499–511. doi:10.1038/nri1391.
  • Atanasov NA, Sargent JL, Parmigiani JP, Palme R, Diggs HE. 2015. Characterization of train-induced vibration and its effect on fecal corticosterone metabolites in mice. J Am Assoc Lab Anim Sci: JAALAS. Nov;54:737–744.
  • Bogdan C, Vodovotz Y, Nathan C. 1991. Macrophage deactivation by interleukin 10. J Exp Med. Dec 1;174:1549–1555. doi:10.1084/jem.174.6.1549.
  • Boyd-Brewer C, McCaffrey R. 2004. Vibroacoustic sound therapy improves pain management and more. Holistic Nurs Pract. May-Jun;18:111–118; quiz 118-119. doi:10.1097/00004650-200405000-00002.
  • Cardoso A, Gil Castro A, Martins AC, Carriche GM, Murigneux V, Castro I, Cumano A, Vieira P, Saraiva M. 2018. The dynamics of interleukin-10-afforded protection during dextran sulfate sodium-induced colitis. Front Immunol. 9:400.
  • Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. 2012. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 7:e44328.
  • Chen YS, Chuang WC, Kung HN, Cheng CY, Huang DY, Sekar P, Lin WW. 2022. Pan-caspase inhibitor zVAD induces necroptotic and autophagic cell death in TLR3/4-stimulated macrophages. Mol Cells. Apr 30;45:257–272. doi:10.14348/molcells.2021.0193.
  • Chow SK, Chim YN, Wang J, Zhang N, Wong RM, Tang N, Leung KS, Cheung WH. 2019. Vibration treatment modulates macrophage polarisation and enhances early inflammatory response in oestrogen-deficient osteoporotic-fracture healing. Eur Cells Mater. Nov 7;38:228–245. doi:10.22203/eCM.v038a16.
  • Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, et al. 2001. Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn’s disease. Gut. Jul;49:42–46. doi:10.1136/gut.49.1.42.
  • Ellinghaus D, Jostins L, Spain SL, Cortes A, Bethune J, Han B, Park YR, Raychaudhuri S, Pouget JG, Hubenthal M, et al. 2016. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. May;48:510–518. doi:10.1038/ng.3528.
  • Feng JH, Jung JS, Hwang SH, Lee SK, Lee SY, Kwak YG, Kim DH, Song CY, Kim MJ, Suh HW, et al. 2022. The mixture of Agrimonia pilosa Ledeb. and Salvia miltiorrhiza Bunge. extract produces analgesic and anti-inflammatory effects in a collagen-induced arthritis mouse model. Anim Cells Syst. 26:166–173. doi:10.1080/19768354.2022.2106302.
  • Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. 1991. IL-10 inhibits cytokine production by activated macrophages. J Immunol. Dec 1;147:3815–3822. doi:10.4049/jimmunol.147.11.3815.
  • Gabrysova L, Howes A, Saraiva M, O’Garra A. 2014. The regulation of IL-10 expression. Curr Top Microbiol Immunol. 380:157–190.
  • Galeazzi M, Bazzichi L, Sebastiani GD, Neri D, Garcia E, Ravenni N, Giovannoni L, Wilton J, Bardelli M, Baldi C, et al. 2014. A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory ‘armed antibody’ for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate. Israel Med Assoc J: IMAJ. Oct;16:666.
  • Garner AM, Norton JN, Kinard WL, Kissling GE, Reynolds RP. 2018. Vibration-induced behavioral responses and response threshold in female C57BL/6 mice. J Am Assoc Lab Anim Sci: JAALAS. Sep 1;57:447–455. doi:10.30802/AALAS-JAALAS-17-00092.
  • Howard M, Muchamuel T, Andrade S, Menon S. 1993. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. Apr 1;177:1205–1208. doi:10.1084/jem.177.4.1205.
  • Huber S, Gagliani N, Esplugues E, O’Connor W, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, et al. 2011. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3 + regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity. Apr 22;34:554–565. doi:10.1016/j.immuni.2011.01.020.
  • Itakura E, Huang RR, Wen DR, Paul E, Wunsch PH, Cochran AJ. 2011. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Modern Pathol. Jun;24:801–809. doi:10.1038/modpathol.2011.5.
  • Jarry A, Bossard C, Bou-Hanna C, Masson D, Espaze E, Denis MG, Laboisse CL. 2008. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J Clin Investig. Mar;118:1132–1142.
  • Jawed Y, Beli E, March K, Kaleth A, Loghmani MT. 2020. Whole-body vibration training increases stem/progenitor cell circulation levels and may attenuate inflammation. Milit Med. Jan 7;185:404–412. doi:10.1093/milmed/usz247.
  • Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. Nov 1;491:119–124. doi:10.1038/nature11582.
  • Kamanaka M, Huber S, Zenewicz LA, Gagliani N, Rathinam C, O’Connor W, Wan YY, Nakae S, Iwakura Y, Hao L, et al. 2011. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J Exp Med. May 9;208:1027–1040. doi:10.1084/jem.20102149.
  • Kantor J, Kantorova L, Mareckova J, Peng D, Vilimek Z. 2019. Potential of vibroacoustic therapy in persons with cerebral palsy: An advanced narrative review. Int J Environ Res Public Health. Oct;16:16.
  • Kennedy J, Verne S, Griffith R, Falto-Aizpurua L, Nouri K. 2015 Sep. Non-invasive subcutaneous fat reduction: a review. J Eur Acad Dermatol Venereol: JEADV. 29:1679–1688. doi:10.1111/jdv.12994.
  • Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. Oct 22;75:263–274. doi:10.1016/0092-8674(93)80068-P.
  • Lage VKS, Lacerda ACR, Neves CDC, Chaves MGA, Soares AA, Lima LP, Martins JB, Matos MA, Vieira ELM, Teixeira AL, et al. 2018. Acute effects of whole-body vibration on inflammatory markers in people with chronic obstructive pulmonary disease: a pilot study. Rehab Res Pract. 2018:5480214.
  • Li B, Alli R, Vogel P, Geiger TL. 2014. IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol. Jul;7:869–878. doi:10.1038/mi.2013.103.
  • Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M. 2016. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflamm. Nov 24;13:297. doi:10.1186/s12974-016-0763-8.
  • Lu Y, Zhao Q, Liu Y, Zhang L, Li D, Zhu Z, Gan X, Yu H. 2018. Vibration loading promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells via p38 MAPK signaling pathway. J Biomech. Apr 11;71:67–75. doi:10.1016/j.jbiomech.2018.01.039.
  • Macatonia SE, Doherty TM, Knight SC, O’Garra A. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol. May 1;150:3755–3765. doi:10.4049/jimmunol.150.9.3755.
  • Mauras A, Chain F, Faucheux A, Ruffie P, Gontier S, Ryffel B, Butel MJ, Langella P, Bermudez-Humaran LG, Waligora-Dupriet AJ. 2018. A new bifidobacteria expression SysTem (BEST) to produce and deliver interleukin-10 in bifidobacterium bifidum. Front Microbiol. 9:3075.
  • McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, Schlimgen R, Lee E, Foster B, Flemming D, et al. 2001. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol. Oct 1;167:4075–4082. doi:10.4049/jimmunol.167.7.4075.
  • Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 19:683–765.
  • Park JM, Park S, Jee YS. 2019. Rehabilitation program combined with local vibroacoustics improves psychophysiological conditions in patients with ACL reconstruction. Medicina (B Aires). Sep 30;55: 659. doi:10.3390/medicina55100659.
  • Phusuntornsakul P, Jitpukdeebodintra S, Pavasant P, Leethanakul C. 2020. Vibration activates the actin/NF-kappaB axis and upregulates IL-6 and IL-8 expression in human periodontal ligament cells. Cell Biol Int. Feb;44:661–670. doi:10.1002/cbin.11267.
  • Reynolds RP, Li Y, Garner A, Norton JN. 2018. Vibration in mice: a review of comparative effects and use in translational research. Anim Models Exp Med. Jun;1:116–124. doi:10.1002/ame2.12024.
  • Rodriguez-Miguelez P, Fernandez-Gonzalo R, Almar M, Mejias Y, Rivas A, de Paz JA, Cuevas MJ, Gonzalez-Gallego J. 2014. Role of toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects. Age (Omaha). 36:9734.
  • Rodriguez-Miguelez P, Fernandez-Gonzalo R, Collado PS, Almar M, Martinez-Florez S, de Paz JA, Gonzalez-Gallego J, Cuevas MJ. 2015. Whole-body vibration improves the anti-inflammatory status in elderly subjects through toll-like receptor 2 and 4 signaling pathways. Mech Ageing Dev. Sep; 150:12–19. doi:10.1016/j.mad.2015.08.002.
  • Sakamoto M, Fukunaga T, Sasaki K, Seiryu M, Yoshizawa M, Takeshita N, Takano-Yamamoto T. 2019. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-kappaB signaling in osteocytes. Bone. Jun;123:56–66. doi:10.1016/j.bone.2019.03.024.
  • Sanyal AJ, Schubert ML. 1993. Endoscopic ligation versus sclerotherapy: is it time to jump on the bandwagon? Gastroenterology. Dec;105:1915–1916.
  • Saraiva M, O’Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol. Mar;10:170–181. doi:10.1038/nri2711.
  • Saraiva M, Vieira P, O’Garra A. 2020. Biology and therapeutic potential of interleukin-10. J Exp Med. Jan 6;217:e20190418. doi:10.1084/jem.20190418 .
  • Shouval DS, Biswas A, Goettel JA, McCann K, Conaway E, Redhu NS, Mascanfroni ID, Al Adham Z, Lavoie S, Ibourk M, et al. 2014. Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity. May 15;40:706–719. doi:10.1016/j.immuni.2014.03.011.
  • Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science. Aug 25;289:1352–1355.
  • Trachsel E, Bootz F, Silacci M, Kaspar M, Kosmehl H, Neri D. 2007. Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis. Arthritis Res Therapy. 9:R9.
  • Weinheimer-Haus EM, Judex S, Ennis WJ, Koh TJ. 2014. Low-intensity vibration improves angiogenesis and wound healing in diabetic mice. PLoS One. 9:e91355.